These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 20846753

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Empiric antimicrobial therapy of community-acquired pneumonia: clinical diagnosis versus procalcitonin levels.
    Cunha BA.
    Scand J Infect Dis; 2009; 41(10):782-4. PubMed ID: 19681019
    [No Abstract] [Full Text] [Related]

  • 3. [Antibiotics or not--procalcitonin can guide therapeutic choices. At least at the emergency department for adults with lower respiratory tract infection].
    Ternhag A, Cars O, Norman C, Struwe J.
    Lakartidningen; 2009; 107(15):985-8. PubMed ID: 20464915
    [No Abstract] [Full Text] [Related]

  • 4. Swine influenza (H1N1) pneumonia: elevated serum procalcitonin levels not due to superimposed bacterial pneumonia.
    Cunha BA, Syed U, Strollo S.
    Int J Antimicrob Agents; 2010 May; 35(5):515-6. PubMed ID: 20188520
    [No Abstract] [Full Text] [Related]

  • 5. Impact of the use of procalcitonin assay in hospitalized adult patients with pneumonia at a community acute care hospital.
    Kook JL, Chao SR, Le J, Robinson PA.
    Infect Control Hosp Epidemiol; 2012 Apr; 33(4):424-6. PubMed ID: 22418643
    [Abstract] [Full Text] [Related]

  • 6. Usefulness of procalcitonin to differentiate typical from atypical community-acquired pneumonia.
    Jereb M, Kotar T.
    Wien Klin Wochenschr; 2006 Apr; 118(5-6):170-4. PubMed ID: 16773483
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Role of C-reactive protein and procalcitonin in differentiation of tuberculosis from bacterial community acquired pneumonia.
    Kang YA, Kwon SY, Yoon HI, Lee JH, Lee CT.
    Korean J Intern Med; 2009 Dec; 24(4):337-42. PubMed ID: 19949732
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.
    Müller B, Harbarth S, Stolz D, Bingisser R, Mueller C, Leuppi J, Nusbaumer C, Tamm M, Christ-Crain M.
    BMC Infect Dis; 2007 Mar 02; 7():10. PubMed ID: 17335562
    [Abstract] [Full Text] [Related]

  • 11. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial.
    Christ-Crain M, Stolz D, Bingisser R, Müller C, Miedinger D, Huber PR, Zimmerli W, Harbarth S, Tamm M, Müller B.
    Am J Respir Crit Care Med; 2006 Jul 01; 174(1):84-93. PubMed ID: 16603606
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index.
    Masiá M, Gutiérrez F, Shum C, Padilla S, Navarro JC, Flores E, Hernández I.
    Chest; 2005 Oct 01; 128(4):2223-9. PubMed ID: 16236878
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.